Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 36
Filtrer
Plus de filtres










Base de données
Gamme d'année
6.
Pigment Cell Melanoma Res ; 25(3): E1-13, 2012 May.
Article de Anglais | MEDLINE | ID: mdl-22417114

RÉSUMÉ

During the 2011 International Pigment Cell Conference (IPCC), the Vitiligo European Taskforce (VETF) convened a consensus conference on issues of global importance for vitiligo clinical research. As suggested by an international panel of experts, the conference focused on four topics: classification and nomenclature; definition of stable disease; definition of Koebner's phenomenon (KP); and 'autoimmune vitiligo'. These topics were discussed in seven working groups representing different geographical regions. A consensus emerged that segmental vitiligo be classified separately from all other forms of vitiligo and that the term 'vitiligo' be used as an umbrella term for all non-segmental forms of vitiligo, including 'mixed vitiligo' in which segmental and non-segmental vitiligo are combined and which is considered a subgroup of vitiligo. Further, the conference recommends that disease stability be best assessed based on the stability of individual lesions rather than the overall stability of the disease as the latter is difficult to define precisely and reliably. The conference also endorsed the classification of KP for vitiligo as proposed by the VETF (history based, clinical observation based, or experimentally induced). Lastly, the conference agreed that 'autoimmune vitiligo' should not be used as a separate classification as published evidence indicates that the pathophysiology of all forms of vitiligo likely involves autoimmune or inflammatory mechanisms.


Sujet(s)
Consensus , Terminologie comme sujet , Vitiligo/classification , Vitiligo/complications , Vitiligo/étiologie , Maladies auto-immunes/classification , Maladies auto-immunes/complications , Maladies auto-immunes/diagnostic , Maladies auto-immunes/étiologie , Congrès comme sujet/organisation et administration , Évolution de la maladie , Humains , Coopération internationale , Vitiligo/diagnostic
8.
Ticks Tick Borne Dis ; 1(4): 197-8, 2010 Dec.
Article de Anglais | MEDLINE | ID: mdl-21771529

RÉSUMÉ

Ticks are vectors of a variety of diseases such as Lyme disease and Japanese spotted fever. We examined an 87-year-old female with multiple tick bites by at least 236 larval Amblyomma testudinarium infestations. Numerous tick bites are generally caused by the six-legged larvae, which were verified in this case by dermoscopy. The present case indicates the diagnostic usefulness of dermoscopy for six-legged larval tick bites.


Sujet(s)
Morsures et piqûres/diagnostic , Tiques , Sujet âgé de 80 ans ou plus , Animaux , Dermoscopie , Femelle , Humains , Larve
13.
Clin Exp Dermatol ; 34(8): e833-6, 2009 Dec.
Article de Anglais | MEDLINE | ID: mdl-20055846

RÉSUMÉ

Lichen amyloidosus (LA) is a type of primary localized cutaneous amyloidosis characterized by multiple pruritic discrete hyperkeratotic papules with amyloid deposition in the papillary dermis. Clinical regression is usually difficult to achieve, even after treatment. In this study, we report a case of an adult man with LA associated with atopic dermatitis (AD) which was successfully treated with narrowband ultraviolet B (NB-UVB) phototherapy, topical corticosteroids and an oral antihistamine. This case suggests that NB-UVB phototherapy may be a useful adjuvant for LA associated with AD.


Sujet(s)
Amyloïdose/thérapie , Eczéma atopique/thérapie , Photothérapie/méthodes , Adulte , Amyloïdose/anatomopathologie , Association thérapeutique , Eczéma atopique/anatomopathologie , Produits dermatologiques/administration et posologie , Antihistaminiques des récepteurs H1/administration et posologie , Humains , Mâle , Résultat thérapeutique
14.
Clin Exp Dermatol ; 34(1): 36-8, 2009 Jan.
Article de Anglais | MEDLINE | ID: mdl-18627392

RÉSUMÉ

Pigmented mammary Paget's disease is a rare variant of mammary Paget's disease. The clinical appearance mimics malignant melanoma. This paper describes a case of asymptomatic, slightly pigmented spots on the right mammary nipple. The pigmented nipple was histopathologically diagnosed as mammary Paget's disease with an underlying intraductal carcinoma. This case suggests the importance of conducting skin biopsies of developing pigmented spots on the nipples in elderly people.


Sujet(s)
Tumeurs du sein/anatomopathologie , Carcinome intracanalaire non infiltrant/anatomopathologie , Mamelons/anatomopathologie , Maladie de Paget du sein/anatomopathologie , Troubles de la pigmentation/anatomopathologie , Femelle , Humains , Adulte d'âge moyen
19.
Oncogene ; 27(23): 3221-32, 2008 May 22.
Article de Anglais | MEDLINE | ID: mdl-18071306

RÉSUMÉ

Adult T-cell leukemia (ATL) is a mature CD4+ T-cell malignancy etiologically associated with human T-cell leukemia virus type 1 (HTLV-1). Primary ATL cells frequently express CCR4 at high levels. Since HTLV-1 Tax does not induce CCR4 expression, transcription factor(s) constitutively active in ATL may be responsible for its strong expression. We identified an activator protein-1 (AP-1) site in the CCR4 promoter as the major positive regulatory element in ATL cells. Among the AP-1 family members, Fra-2, JunB and JunD are highly expressed in fresh primary ATL cells. Consistently, the Fra-2/JunB and Fra-2/JunD heterodimers strongly activated the CCR4 promoter in Jurkat cells. Furthermore, Fra-2 small interfering RNA (siRNA) or JunD siRNA, but not JunB siRNA, effectively reduced CCR4 expression and cell growth in ATL cells. Conversely, Fra-2 or JunD overexpression promoted cell growth in Jurkat cells. We identified 49 genes, including c-Myb, BCL-6 and MDM2, which were downregulated by Fra-2 siRNA in ATL cells. c-Myb, BCL-6 and MDM2 were also downregulated by JunD siRNA. As Fra-2, these proto-oncogenes were highly expressed in primary ATL cells but not in normal CD4+ T cells. Collectively, aberrantly expressed Fra-2 in association with JunD may play a major role in CCR4 expression and oncogenesis in ATL.


Sujet(s)
Prolifération cellulaire , Antigène-2 apparenté à fos/génétique , Régulation de l'expression des gènes dans la leucémie , Leucémie-lymphome à cellules T de l'adulte/génétique , Récepteurs CCR4/génétique , Sites de fixation , Techniques de culture cellulaire , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Antigène-2 apparenté à fos/antagonistes et inhibiteurs , Antigène-2 apparenté à fos/métabolisme , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes dans la leucémie/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes dans la leucémie/physiologie , Humains , Cellules Jurkat , Leucémie-lymphome à cellules T de l'adulte/anatomopathologie , Séquençage par oligonucléotides en batterie , Régions promotrices (génétique) , Liaison aux protéines , Protéines proto-oncogènes c-jun/antagonistes et inhibiteurs , Protéines proto-oncogènes c-jun/génétique , Protéines proto-oncogènes c-jun/métabolisme , Petit ARN interférent/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...